About "The 17th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry

PDF for printing

December 21, 2023
Japan Pharmaceutical Manufacturers Association


The Japan Pharmaceutical Manufacturers Association (JPMA) is pleased to announce that the results of the "17th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry" (the "Survey"), conducted this year, are now available on the JPMA website.
The 17th Survey on Sei-katsu-sha Attitudes Toward Drugs and the Pharmaceutical Industry
https://www.jpma.or.jp/news_room/issue/survey/index.html
The purpose of this survey is to understand sei-katsu-sha understanding and perception of ethical drugs and the JPMA industry, and to provide basic data for the implementation of JPMA's public relations activities.
According to the results of this year's survey, the level of trust in the pharmaceutical industry was 88%, indicating that the level of trust in the industry is as high as ever. In terms of the image of the pharmaceutical industry, positive responses such as "an industry that is highly necessary to society" and "an industry with strong technological capabilities" were among the top responses. In addition, 55% of the respondents were "aware" of the medical data system, and a high 70% said they "want" pharmaceutical companies to "utilize" this data. We believe that these results are an indication of the high expectations of consumers, including patients, for the activities of the pharmaceutical industry in developing new drugs and creating safe drugs. (Chapter 2: Image and Expectations of the Pharmaceutical Industry and Perception of Its Activities)
In the social life of the pandemic of novel coronavirus infection (COVID-19), With/After COVID-19, the pharmaceutical industry is expected to continue to fulfill its mission of the need for therapeutic drugs and vaccines and the stable supply of pharmaceutical products. The percentage of respondents who said that their "attitude toward health, medicine, and medical care" changed after the pandemic was 34%, of which 65% said that their "health awareness has increased. (Chapter 3: Sei-katsu-sha Health and Their Relationship with Drugs and Medical Care)
In order to meet the expectations of our stakeholders and continue to earn their trust even in a changing social environment, we will make the most of the results of this survey and continue to promote JPMA activities in the future.

Attachment

 

For inquiries regarding this survey, please contact

Japan Pharmaceutical Manufacturers Association

Phone: +81-3-3241-0374
03-3241-0374

Share this page

TOP